✦ LIBER ✦

Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer

✍ Scribed by G. Bolis; G. Bortolozzi; G. Carinelli; M. D'Incalci; F. Gramellini; L. Morasca; C. Mangioni

Book ID: 112285966
Publisher: Springer
Year: 1980
Tongue: English
Weight: 345 KB
Volume: 4
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00254034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infusional cisplatin plus cyclophosphami

Infusional cisplatin plus cyclophosphamide in advanced ovarian cancer

✍ Jacob Lokich; Thomas Zipoli; Robert Green 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Continuous low-dose cyclophosphamide (NS

Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancer

✍ Costantino Mangioni; Giorgio Bolis; Nicola Natale; Luciano Morasca 📂 Article 📅 1976 🏛 Elsevier Science ⚖ 293 KB

cis-platinum, adriamycin, and hexamethyl

cis-platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma

✍ J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 411 KB

Fifty-three evaluable patients with disseminated ovarian carcinoma (FIGO Ill or IV) not treated with prior chemotherapy were randomized to receive either combination chemotherapy consisting of cis-platinum 40 mg/m e IV on day 1, adriamycin 40 mg/m 2 IV on day 1, and hexamethylmelamine 150 mg/m 2 PO

A randomized comparison of melphalan ver

A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma

✍ G. A. Omura; C. P. Morrow; J. A. Blessing; A. Miller; H. J. Buchsbaum; H. D. Hom 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

Comparative trial of low-dose adriamycin

Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer

✍ Richard E. Lloyd; Stephen E. Jones; Sydney E. Salmon 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Hexamethylmelamine, adriamycin, and cycl

Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versuscis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: A randomized clinical trial

✍ Cristiana Sessa; Giorgio Bolis; Nicoletta Colombo; Maurizio D'Incalci; Bernadett 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 659 KB